Home/Recalls/CANADA-75380
Health CanadaType II

JAMP-Guanfacine XR 4 mg: Foreign matter

Published: April 10, 2024Recall ID: 75380Category: generalCountry: Canada

Reason for Recall / Hazard

Product quality - Product safety

Product Description & Identification

Check your or your child's pill bottle to ensure that the green JAMP Guanfacine XR 4mg tablets do not have any brown or amber-coloured stains. If stains are identified, or if you are unsure, return it to your pharmacy for a replacement.Talk to a health care professional if you have questions or have health concerns.Contact JAMP Pharma Corporation by calling 450-449-4326 (option 3) or 1-866-399-9091 (option 3), or by email at custjamp@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.Additional information for health professionals:Health care professionals, such as pharmacists, should check bottles of Guanfacine XR 4 mg tablets before dispensing and report any unusual tablets or other issue to the company and to Health Canada.

Affected Products

JAMP-Guanfacine XR 4 mg

Additional Source Details

FieldValue
N I D75380
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/jamp-guanfacine-xr-4-mg-foreign-matter
IssueProduct quality - Product safety
TitleJAMP-Guanfacine XR 4 mg: Foreign matter
ProductJAMP-Guanfacine XR 4 mg
Archived0
CategoryDrugs
Last updated2024-04-10
OrganizationDrugs and health products
Recall classType II
What you should doCheck your or your child's pill bottle to ensure that the green JAMP Guanfacine XR 4mg tablets do not have any brown or amber-coloured stains. If stains are identified, or if you are unsure, return it to your pharmacy for a replacement.Talk to a health care professional if you have questions or have health concerns.Contact JAMP Pharma Corporation by calling 450-449-4326 (option 3) or 1-866-399-9091 (option 3), or by email at custjamp@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.Additional information for health professionals:Health care professionals, such as pharmacists, should check bottles of Guanfacine XR 4 mg tablets before dispensing and report any unusual tablets or other issue to the company and to Health Canada.

Overview

  • Recalling FirmDrugs and health products
  • Risk LevelType II
Official Agency Alert